|
1
|
Ferlay J, Soerjomataram I, Ervik M,
Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D and
Bray F: GLOBOCAN 2012: Estimated Cancer Incidence, Mortality and
Prevalence Worldwide in 2012 v1.0. IARC CancerBase No. 11. IARC;
Lyon: 2012, https://publications.iarc.fr/Databases/Iarc-Cancerbases/GLOBOCAN-2012-Estimated-Cancer-Incidence-Mortality-And-Prevalence-Worldwide-In-2012-V1.0-2012.
|
|
2
|
Motola-Kuba D, Zamora-Valdes D, Uribe M
and Mendez-Sanchez N: Hepatocellular carcinoma. An overview Ann
Hepatol. 5:16–24. 2006. View Article : Google Scholar
|
|
3
|
Fattovich G, Stroffolini T, Zagni I and
Donato F: Hepatocellular carcinoma in cirrhosis: Incidence and risk
factors. Gastroenterology. 127(5 Suppl 1): S35–S50. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Venook AP, Papandreou C, Furuse J and de
Guevara LL: The incidence and epidemiology of hepatocellular
carcinoma: A global and regional perspective. Oncologist. 15(Suppl
4): S5–S13. 2010. View Article : Google Scholar
|
|
5
|
Wei Y, Neuveut C, Tiollais P and Buendia
MA: Molecular biology of the hepatitis B virus and role of the X
gene. Pathol Biol (Paris). 58:267–272. 2010. View Article : Google Scholar
|
|
6
|
Luo N, Cai Y, Zhang J, Tang W, Slagle BL,
Wu X and He S: The C-terminal region of the hepatitis B virus X
protein is required for its stimulation of HBV replication in
primary mouse hepato-cytes. Virus Res. 165:170–178. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Geng X, Huang C, Qin Y, McCombs JE, Yuan
Q, Harry BL, Palmer AE, Xia NS and Xue D: Hepatitis B virus X
protein targets Bcl-2 proteins to increase intracellular calcium,
required for virus replication and cell death induction. Proc Natl
Acad Sci USA. 109:18471–18476. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sze KM, Chu GK, Lee JM and Ng IO:
C-terminal truncated hepatitis B virus x protein is associated with
metastasis and enhances invasiveness by C-Jun/matrix
metalloproteinase protein 10 activation in hepatocellular
carcinoma. Hepatology. 57:131–139. 2013. View Article : Google Scholar
|
|
9
|
Yip WK, Cheng AS, Zhu R, Lung RW, Tsang
DP, Lau SS, Chen Y, Sung JG, Lai PB, Ng EK, et al:
Carboxyl-terminal truncated HBx regulates a distinct microRNA
transcription program in hepatocellular carcinoma development. PLoS
One. 6:e228882011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xiao CX, Yang XN, Huang QW, Zhang YQ, Lin
BY, Liu JJ, Liu YP, Jazag A, Guleng B and Ren JL: ECHS1 acts as a
novel HBsAg-binding protein enhancing apoptosis through the
mitochondrial pathway in HepG2 cells. Cancer Lett. 330:67–73. 2013.
View Article : Google Scholar
|
|
11
|
Liu YP, Yang XN, Jazag A, Pan JS, Hu TH,
Liu JJ, Guleng B and Ren JL: HBsAg inhibits the translocation of
JTB into mitochondria in HepG2 cells and potentially plays a role
in HCC progression. PLoS One. 7:e369142012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Pan JS, Zhou F, Xie CX, Cai JY, Chen JM,
Zhang ZP, Dong J, Xu HZ, Shi HX and Ren JL: Aldolase A-HBsAg
interaction and its effect on ultraviolet radiation induced
apoptosis in 293FT cells. J Gastroenterol Hepatol. 25:1702–1709.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sung WK, Zheng H, Li S, Chen R, Liu X, Li
Y, Lee NP, Lee WH, Ariyaratne PN, Tennakoon C, et al: Genome-wide
survey of recurrent HBV integration in hepatocellular carcinoma.
Nat Genet. 44:765–769. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Shafritz DA, Shouval D, Sherman HI,
Hadziyannis SJ and Kew MC: Integration of hepatitis B virus DNA
into the genome of liver cells in chronic liver disease and
hepatocellular carcinoma. Studies in percutaneous liver biopsies
and post-mortem tissue specimens. N Engl J Med. 305:1067–1073.
1981. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Park YM, Jang JW, Yoo SH, Kim SH, Oh IM,
Park SJ, Jang YS and Lee SJ: Combinations of eight key mutations in
the X/preC region and genomic activity of hepatitis B virus are
associated with hepatocellular carcinoma. J Viral Hepat.
21:171–177. 2014. View Article : Google Scholar
|
|
16
|
Xu HZ, Liu YP, Guleng B and Ren JL:
Hepatitis B virus-related hepatocellular carcinoma: Pathogenic
mechanisms and novel therapeutic interventions. Gastrointest
Tumors. 1:135–145. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sell S and Leffert HL: Liver cancer stem
cells. J Clin Oncol. 26:2800–2805. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Das A and Maini MK: Innate and adaptive
immune responses in hepatitis B virus infection. Dig Dis.
28:126–132. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Rogozin IB, Basu MK, Jordan IK, Pavlov YI
and Koonin EV: APOBEC4, a new member of the AID/APOBEC family of
polynucleotide (deoxy)cytidine deaminases predicted by
computational analysis. Cell Cycle. 4:1281–1285. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Prochnow C, Bransteitter R and Chen XS:
APOBEC deami-nases-mutases with defensive roles for immunity. Sci
China C Life Sci. 52:893–902. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Teng B, Burant CF and Davidson NO:
Molecular cloning of an apolipoprotein B messenger RNA editing
protein. Science. 260:1816–1819. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Navaratnam N, Morrison JR, Bhattacharya S,
Patel D, Funahashi T, Giannoni F, Teng BB, Davidson NO and Scott J:
The p27 catalytic subunit of the apolipoprotein B mRNA editing
enzyme is a cyti-dine deaminase. J Biol Chem. 268:20709–20712.
1993.PubMed/NCBI
|
|
23
|
Mangeat B, Turelli P, Caron G, Friedli M,
Perrin L and Trono D: Broad antiretroviral defence by human
APOBEC3G through lethal editing of nascent reverse transcripts.
Nature. 424:99–103. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Har ris RS, Bishop KN, Sheehy AM, Craig
HM, Petersen-Mahrt SK, Watt IN, Neuberger MS and Malim MH: DNA
deamination mediates innate immunity to retroviral infection. Cell.
113:803–809. 2003. View Article : Google Scholar
|
|
25
|
Suspene R, Guetard D, Henry M, Sommer P,
Wain-Hobson S and Vartanian JP: Extensive editing of both hepatitis
B virus DNA strands by APOBEC3 cytidine deaminases in vitro and in
vivo. Proc Natl Acad Sci USA. 102:8321–8326. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Muramatsu M, Sankaranand VS, Anant S,
Sugai M, Kinoshita K, Davidson NO and Honjo T: Specific expression
of activation-induced cytidine deaminase (AID), a novel member of
the RNA-editing deaminase family in germinal center B cells. J Biol
Chem. 274:18470–18476. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Neuberger MS, Harris RS, Di Noia J and
Petersen-Mahrt SK: Immunity through DNA deamination. Trends Biochem
Sci. 28:305–312. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liao W, Hong SH, Chan BH, Rudolph FB,
Clark SC and Chan L: APOBEC-2, a cardiac- and skeletal
muscle-specific member of the cytidine deaminase supergene family.
Biochem Biophys Res Commun. 260:398–404. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Anant S, Mukhopadhyay D, Sankaranand V,
Kennedy S, Henderson JO and Davidson NO: ARCD-1, an
apobec-1-related cytidine deaminase, exerts a dominant negative
effect on C to U RNA editing. Am J Physiol Cell Physiol.
281:C1904–C1916. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Matsumoto T, Marusawa H, Endo Y, Ueda Y,
Matsumoto Y and Chiba T: Expression of APOBEC2 is transcriptionally
regulated by NF-kappaB in human hepatocytes. FEBS Lett.
580:731–735. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Okuyama S, Marusawa H, Matsumoto T, Ueda
Y, Matsumoto Y, Endo Y, Takai A and Chiba T: Excessive activity of
apolipoprotein B mRNA editing enzyme catalytic polypeptide 2
(APOBEC2) contributes to liver and lung tumorigenesis. Int J
Cancer. 130:1294–1301. 2012. View Article : Google Scholar
|
|
32
|
Bandopadhyay M, Sarkar N, Datta S, Das D,
Pal A, Panigrahi R, Banerjee A, Panda CK, Das C, Chakrabarti S and
Chakravarty R: Hepatitis B virus X protein mediated suppression of
miRNA-122 expression enhances hepatoblastoma cell proliferation
through cyclin G1-p53 axis. Infect Agent Cancer. 11:402016.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Scaglioni PP, Melegari M and Wands JR:
Posttranscriptional regulation of hepatitis B virus replication by
the precore protein. J Virol. 71:345–353. 1997.PubMed/NCBI
|
|
34
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
35
|
Vallee A, Lecarpentier Y and Vallee JN:
Targeting the canonical WNT/β-catenin pathway in cancer treatment
using non-steroidal anti-inflammatory drugs. Cells. 8:E7262019.
View Article : Google Scholar
|
|
36
|
Kumari N, Dwarakanath BS, Das A and Bhatt
AN: Role of interleukin-6 in cancer progression and therapeutic
resistance. Tumour Biol. 37:11553–11572. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Göktuna SI, Diamanti MA and Chau TL: IKKs
and tumor cell plasticity. FEBS J. 285:2161–2181. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zubair H, Azim S, Srivastava SK, Ahmad A,
Bhardwaj A, Khan MA, Patel GK, Arora S, Carter JE, Singh S and
Singh AP: Glucose metabolism reprogrammed by overexpression of
IKKepsilon promotes pancreatic tumor growth. Cancer Res.
76:7254–7264. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Balkwill F: TNF-alpha in promotion and
progression of cancer. Cancer Metastasis Rev. 25:409–416. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Li C, Wang Y, Wang S, Wu B, Hao J, Fan H,
Ju Y, Ding Y, Chen L, Chu X, et al: Hepatitis B virus mRNA-mediated
miR-122 inhibition upregulates PTTG1-binding protein, which
promotes hepatocellular carcinoma tumor growth and cell invasion. J
Virol. 87:2193–2205. 2013. View Article : Google Scholar :
|
|
41
|
Cascalho M: Advantages and disadvantages
of cytidine deamination. J Immunol. 172:6513–6518. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Chen SH, Habib G, Yang CY, Gu ZW, Lee BR,
Weng SA, Silberman SR, Cai SJ, Deslypere JP and Rosseneu M:
Apolipoprotein B-48 is the product of a messenger RNA with an
organ-specific in-frame stop codon. Science. 238:363–366. 1987.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Yamanaka S, Balestra ME, Ferrell LD, Fan
J, Arnold KS, Taylor S, Taylor JM and Innerarity TL: Apolipoprotein
B mRNA-editing protein induces hepatocellular carcinoma and
dysplasia in transgenic animals. Proc Natl Acad Sci USA.
92:8483–8487. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Okazaki IM, Hiai H, Kakazu N, Yamada S,
Muramatsu M, Kinoshita K and Honjo T: Constitutive expression of
AID leads to tumorigenesis. J Exp Med. 197:1173–1181. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Morisawa T, Marusawa H, Ueda Y, Iwai A,
Okazaki IM, Honjo T and Chiba T: Organ-specific profiles of genetic
changes in cancers caused by activation-induced cytidine deaminase
expression. Int J Cancer. 123:2735–2740. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Girard M, Jacquemin E, Munnich A, Lyonnet
S and Henrion-Caude A: miR-122, a paradigm for the role of
microRNAs in the liver. J Hepatol. 48:648–656. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Lewis AP and Jopling CL: Regulation and
biological function of the liver-specific miR-122. Biochem Soc
Trans. 38:1553–1557. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Gramantieri L, Ferracin M, Fornari F,
Veronese A, Sabbioni S, Liu CG, Calin GA, Giovannini C, Ferrazzi E,
Grazi GL, et al: Cyclin G1 is a target of miR-122a, a microRNA
frequently down-regulated in human hepatocellular carcinoma. Cancer
Res. 67:6092–6099. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Fan CG, Wang CM, Tian C, Wang Y, Li L, Sun
WS, Li RF and Liu YG: miR-122 inhibits viral replication and cell
proliferation in hepatitis B virus-related hepatocellular carcinoma
and targets NDRG3. Oncol Rep. 26:1281–1286. 2011.PubMed/NCBI
|
|
50
|
Lin CJ, Gong HY, Tseng HC, Wang WL and Wu
JL: miR-122 targets an anti-apoptotic gene, Bcl-w, in human
hepatocellular carcinoma cell lines. Biochem Biophys Res Commun.
375:315–320. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Barajas JM, Reyes R, Guerrero MJ, Jacob
ST, Motiwala T and Ghoshal K: The role of miR-122 in the
dysregulation of glucose-6-phosphate dehydrogenase (G6PD)
expression in hepatocellular cancer. Sci Rep. 8:91052018.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Bai S, Nasser MW, Wang B, Hsu SH, Datta J,
Kutay H, Yadav A, Nuovo G, Kumar P and Ghoshal K: MicroRNA-122
inhibits tumorigenic properties of hepatocellular carcinoma cells
and sensitizes these cells to sorafenib. J Biol Chem.
284:32015–32027. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Tsai WC, Hsu PW, Lai TC, Chau GY, Lin CW,
Chen CM, Lin CD, Liao YL, Wang JL, Chau YP, et al: MicroRNA-122, a
tumor suppressor microRNA that regulates intrahepatic metastasis of
hepatocellular carcinoma. Hepatology. 49:1571–1582. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Waidmann O, Bihrer V, Pleli T, Farnik H,
Berger A, Zeuzem S, Kronenberger B and Piiper A: Serum microRNA-122
levels in different groups of patients with chronic hepatitis B
virus infection. J Viral Hepat. 19:e58–e65. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Song le H, Binh VQ, Duy DN, Kun JF, Bock
TC, Kremsner PG and Luty AJ: Serum cytokine profiles associated
with clinical presentation in vietnamese infected with hepatitis B
virus. J Clin Virol. 28:93–103. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Porta C, De Amici M, Quaglini S, Paglino
C, Tagliani F, Boncimino A, Moratti R and Corazza GR: Circulating
interleukin-6 as a tumor marker for hepatocellular carcinoma. Ann
Oncol. 19:353–358. 2008. View Article : Google Scholar
|
|
57
|
Lan T, Chang L, Wu L and Yuan YF: IL-6
plays a crucial role in HBV infection. J Clin Transl Hepatol.
3:271–276. 2015. View Article : Google Scholar
|
|
58
|
Wang H and Ryu WS: Hepatitis B virus
polymerase blocks pattern recognition receptor signaling via
interaction with DDX3: Implications for immune evasion. PLoS
Pathog. 6:e10009862010. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Marinos G, Naoumov NV, Rossol S, Torre F,
Wong PY, Gallati H, Portmann B and Williams R: Tumor necrosis
factor receptors in patients with chronic hepatitis B virus
infection. Gastroenterology. 108:1453–1463. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Thorgeirsson SS and Grisham JW: Molecular
pathogenesis of human hepatocellular carcinoma. Nat Genet.
31:339–346. 2002. View Article : Google Scholar : PubMed/NCBI
|
